Vera Therapeutics Presents Positive 72-Week Data Showing eGFR Stabilization in the Phase 2b ORIGIN Clinical Trial OLE in IgA Nephropathy by Seini Moimoi | Jan 25, 2024 | Portfolio News
Endeavor BioMedicines Successfully Completes Phase 2a Trial Of ENV-101 In Patients With Idiopathic Pulmonary Fibrosis by Seini Moimoi | Jan 24, 2024 | Portfolio News
Quanta Announces IND Clearance by U.S. FDA for QTX3034, G12D-Preferring Multi-KRAS Inhibitor, and Other Pipeline Updates by Seini Moimoi | Jan 4, 2024 | Portfolio News
Nalu Medical, Inc. Announces $65 Million Equity Financing to Advance Treatment for Chronic Neuropathic Pain by Seini Moimoi | Jan 3, 2024 | Portfolio News
